US Patent 10781450 Antisense molecules and methods for treating pathologies

Overview Structured Data Issues Contributors Activity

Is a

Patent

Patent attributes

Current Assignee

Sarepta Therapeutics

Patent Jurisdiction

United States Patent and Trademark Office

Patent Number

107814500

Date of Patent

September 22, 2020

Patent Application Number

163579180

Date Filed

March 19, 2019

Patent Citations

‌

US Patent 10227590 Antisense oligonucleotides for inducing exon skipping and methods of use thereof

‌

US Patent 10287586 Antisense molecules and methods for treating pathologies

‌

US Patent 10266827 Antisense oligonucleotides for inducing exon skipping and methods of use thereof

Patent Citations Received

‌

US Patent 11382981 Exon skipping oligomer conjugates for muscular dystrophy

Patent Primary Examiner

‌

Tracy Vivlemore

No article content yet.

Timeline

No Timeline data yet.

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

References

Find more entities like US Patent 10781450 Antisense molecules and methods for treating pathologies

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.

Open Query Tool

Access by API